[1]
M. Tomić, “The preoperative management of dabigatran and its specific antidote idarucizumab in patients with nonvalvular atrial fibrillation – case reports”, arhfarm, vol. 70, no. Notebook 5, pp. 310–318, Nov. 2020, doi: 10.5937/arhfarm70-28176.